BCM
ABMD

Buckhead Capital Management’s Abiomed Inc ABMD Stock Holding History

Buckhead Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,886
Closed -$463K – 124
2022
Q3 		$463K Hold
1,886
– – 0.12% 95
2022
Q2 		$467K Sell
1,886
-1,155
-38% -$312K 0.12% 97
2022
Q1 		$1.01M Buy
3,041
+101
+3% +$31.1K 0.22% 86
2021
Q4 		$1.06M Hold
2,940
– – 0.22% 86
2021
Q3 		$957K Buy
2,940
+593
+25% +$201K 0.21% 87
2021
Q2 		$733K Buy
2,347
+72
+3% +$22.1K 0.16% 93
2021
Q1 		$725K Buy
2,275
+670
+42% +$214K 0.17% 86
2020
Q4 		$520K Buy
1,605
+560
+54% +$155K 0.13% 92
2020
Q3 		$290K Hold
1,045
– – 0.08% 102
2020
Q2 		$252K Buy
+1,045
New +$210K 0.08% 100

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Buckhead Capital Management's ABMD Position: Q4 2022 in Review

Buckhead Capital Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,886 shares — an estimated $463K sold.

Buckhead Capital Management first reported a position in ABMD in Q2 2020 and held it in 10 quarters. The position peaked at $1.06M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Buckhead Capital Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Buckhead Capital Management sold 1,886 Abiomed Inc shares in Q4 2022, an estimated $463K.
  • Buckhead Capital Management first reported a position in Abiomed Inc in Q2 2020 and held it in 10 quarters.
  • Buckhead Capital Management's Abiomed Inc position peaked at $1.06M in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Buckhead Capital Management's 13F filing for Q4 2022, filed 8 Feb 2023.